Gestational diabetes mellitus and risk of future maternal cardiovascular disease

Kim, Catherine

doi:10.1586/erc.10.167

Cited by 12 publications

(12 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…found that CVD risk factor was not increased in women with a history of GDM if T2DM is not developed in the future 11 . The different results of these studies may be explained by various lengths of follow‐up, diagnostic criteria and selection of the initial population with GDM, race, age and the BMI range of the study population 6,7 . Further, the majority of those studies was not community‐based and their control groups were not age‐ and BMI‐matched.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Follow‐up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population‐based cohort study

Tehrani

Hashemi

Hasheminia

et al. 2012

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 97%

“…demonstrated no association between prior GDM and development of T2DM late in life 24 . It seems that the cumulative incidence of type 2 diabetes varied widely among studies and differences were largely explained by type of the study, recruitment of study subjects and various lengths of follow‐up 6 …”

Section: Discussionmentioning

confidence: 99%

Follow‐up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population‐based cohort study

Tehrani

Hashemi

Hasheminia

et al. 2012

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…Given this risk, the postpartum period provides a window of opportunity for diabetes prevention in women with recent GDM [6, 7]. However, few studies have enrolled women with recent GDM for interventions in the postpartum period [8]. This may be due, at least in part, to difficulties recruiting this cohort.…”

Section: Introductionmentioning

confidence: 99%

Employing a Multi-level Approach to Recruit a Representative Sample of Women with Recent Gestational Diabetes Mellitus into a Randomized Lifestyle Intervention Trial

Nicklas

Skurnik

Zera

et al. 2015

Matern Child Health J

View full text Add to dashboard Cite

Objective The postpartum period is a window of opportunity for diabetes prevention in women with recent gestational diabetes (GDM), but recruitment for clinical trials during this period of life is a major challenge. Methods We adapted a social-ecologic model to develop a multi-level recruitment strategy at the macro (high or institutional level), meso (mid or provider level), and micro (individual) levels. Our goal was to recruit 100 women with recent GDM into the Balance after Baby randomized controlled trial over a 17-month period. Participants were asked to attend three in-person study visits at 6 weeks, 6 months, and 12 months postpartum. They were randomized into a control arm or a web-based intervention arm at the end of the baseline visit at six weeks postpartum. At the end of the recruitment period, we compared population characteristics of our enrolled subjects to the entire population of women with GDM delivering at Brigham and Women's Hospital (BWH). Results We successfully recruited 107 of 156 (69%) women assessed for eligibility, with the majority (92) recruited during pregnancy at a mean 30 (SD± 5) weeks of gestation, and 15 recruited postpartum, at a mean 2 (SD±3) weeks postpartum. 78 subjects attended the initial baseline visit, and 75 subjects were randomized into the trial at a mean 7 (SD±2) weeks postpartum. The recruited subjects were similar in age and race/ethnicity to the total population of 538 GDM deliveries at BWH over the 17-month recruitment period. Conclusions Our multilevel approach allowed us to successfully meet our recruitment goal and recruit a representative sample of women with recent GDM. We believe that our most successful strategies included using a dedicated in-person recruiter, integrating recruitment into clinical flow, allowing for flexibility in recruitment, minimizing barriers to participation, and using an opt-out strategy with providers. Although the majority of women were recruited while pregnant, women recruited in the early postpartum period were more likely to present for the first study visit. Given the increased challenges of recruiting postpartum women with GDM into research studies, we believe our findings will be useful to other investigators seeking to study this population.

show abstract

“…Introduction P regnancy complications, including gestational diabetes, [1][2][3][4][5] hypertension in pregnancy, [6][7][8][9][10] low birthweight, [11][12][13] and preterm delivery, 12,14 are risk factors for developing cardiovascular disease (CVD) later in life. [15][16][17][18] The 2011 American Heart Association (AHA) ''Guidelines for the Prevention of Cardiovascular Disease in Women'' recommended that healthcare providers take a history of these pregnancies to identify women whose pregnancy history places them at increased risk for future CVD.…”

mentioning

confidence: 99%

Pregnancy Complications as Markers for Subsequent Maternal Cardiovascular Disease: Validation of a Maternal Recall Questionnaire

Carter

Stuart

Farland

et al. 2015

Journal of Women's Health

View full text Add to dashboard Cite

Background: We designed and tested the validity of a questionnaire to characterize maternal recall of pregnancy complications associated with increased future cardiovascular disease risk, based on the 2011 American Heart Association (AHA) guidelines. Methods: A maternal recall questionnaire of pregnancy history was administered to 971 patients who had participated in a previous cohort study of 1,608 pregnant women. Medical records from the study pregnancy served as the gold standard. Prevalence, sensitivity (sens), specificity (spec), positive predictive value (PPV), negative predictive value (NPV), and/or Spearman's correlation coefficients (r) were calculated for each question. Results: A total of 526 (54%) individuals recontacted responded. Respondents were more likely to be older, white, educated, and nulliparous and were less likely to deliver low-birthweight infants in the study pregnancy than were individuals who did not respond. Mean length of recall was 4.35 years (standard deviation [SD] 0.46) postpartum. Maternal recall was most accurate for gestational diabetes (sens: 92%, spec: 98%, PPV: 79%, NPV: 99%), infant birthweight (r = 0.95), and gestation length (r = 0.85). Maternal recall was modest for preeclampsia (sens: 79%, spec: 97%, PPV: 68%, NPV: 98%) and pregnancy-associated hypertension, including preeclampsia or gestational hypertension (sens: 60%, spec: 95%, PPV: 64%, NPV: 94%).Conclusions: This validation study demonstrated that the majority of women could accurately recall a history of gestational diabetes, infant birthweight, and gestational age at delivery, 4 years postpartum on average. Recall of preeclampsia and pregnancy-associated hypertension overall was modest. Maternal report of these pregnancy conditions may help clinicians identify women at increased risk for cardiovascular disease.

show abstract

Gestational diabetes mellitus and risk of future maternal cardiovascular disease

Cited by 12 publications

References 19 publications

Follow‐up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population‐based cohort study

Follow‐up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population‐based cohort study

Employing a Multi-level Approach to Recruit a Representative Sample of Women with Recent Gestational Diabetes Mellitus into a Randomized Lifestyle Intervention Trial

Pregnancy Complications as Markers for Subsequent Maternal Cardiovascular Disease: Validation of a Maternal Recall Questionnaire

Contact Info

Product

Resources

About